The recent Reuter’s report – Beyond COVID-19: Life sciences reimagined  – highlighted how fast life science companies are moving into digital customer engagement. According to the survey which underpinned the report, 84% of companies are increasing digital investments.
That’s not really news. We all know how much the pandemic has impacted the industry’s ability to engage with healthcare professionals (HPCs) and the extent to which companies have switched to digital to maintain HCP relationships. What interesting, however, is where those investments were being directed – and how that might change in the future.
How pharma is responding to COVID
At the start of the pandemic, remote detailing, webinars, e-meetings, and email were by far the most popular channels. Looking forward they remain pre-eminent, but a slightly different picture emerges.
One big change that stood out to us at Anthill is the increasing interest – and expected investment in – self-directed web detailing. While this barely made the list of key channels during the immediate response to COVID, companies expect to invest in ‘self-detailing’ in the near future – more so than even approved email.
Self-detailing is a channel that Anthill has been championing for a number of years now. We originally encouraged clients to consider it because self-detailing is a great way to engage HCPs between rep visits. In fact, we created an eBook about self-detailing a while ago titled ‘Mind the Gap’ highlighting these specific benefits.
“Self-detailing is a channel that Anthill has been championing for a number of years”
In the eBook, we explained how ‘chatbot’ technology can be used in self-detailing systems to provide a guided experience for HCPs – even though no rep is present– and how to achieve this kind of interaction in a fully compliant way. We also explored wider uses for chatbots in pharma communication outside of the self-detailing channel.
Since the eBook was launched, we’ve done a number of self-detailing projects for forward thinking pharma companies. These went very well but we’ve still learned a great deal about the best ways to approach these initiatives.
As always, we’re keen to share knowledge. So, earlier this year we updated ‘Mind the Gap’ with new information – with more detail on how to ensure a smooth approval process and how best to structure chatbot ‘conversations’.
Over this past year,we have experienced an unnatural withdrawal from society. Inevitably, perpetuated feelings of loneliness, uncertainty, and loss of control during this time have taken a toll on mental health and well-being of many around the globe. If true for the general population, this phenomenon hits harder for those living with multiple sclerosis.
Remote detailing, and generally any kind of remote engagement, has been increasing steadily over the last decade. It was clear that it would have a big part to play in pharma sales and marketing in the future. Last year turbocharged that. Now it’s an essential channel – and is growing exponentially.